A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine selectively activates chloride efflux from human epithelial and mouse fibroblast cell lines expressing the cystic fibrosis transmembrane regulator delta F508 mutation

Biochemistry
C Guay-BroderH B Pollard

Abstract

Cystic fibrosis is an autosomal recessive disorder affecting chloride transport in pancreas, lung, and other tissues, which is caused by mutations in the cystic fibrosis transmembrane regulator (CFTR). The A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (CPX) stimulates 36Cl- efflux from pancreatic CFPAC-1 cells which bear the delta F508 genotype common to most cases of cystic fibrosis [Eidelman et al. (1992) Proc. Natl. Acad. Sci. U.S.A. 89, 5562-5566]. By contrast, correction of the cystic fibrosis defect by retrovirus-mediated gene transfer renders the resulting CFPAC-PLJ-CFTR cells insensitive to CPX. We now report that CPX also activates chloride efflux from the CF tracheal epithelial cell line IB3-1 bearing a delta F508 allele, but not if the IB3-1 cells have been repaired by transfection of the wild-type CFTR gene. Similar results were obtained with recombinant NIH 3T3 cells, in which CPX activates 36Cl- efflux from cells expressing the CFTR (delta F508) gene product but not from 3T3 cells expressing the wild-type CFTR. In all three cell types expressing CFTR (delta F508), CPX was found to activate 36Cl- efflux in a dose-dependent manner over the concentration range of 1-30 nM and then gradually lose potency at...Continue Reading

Citations

Jan 22, 2002·Pediatric Pulmonology·Nael A McCartyRichard C Ahrens
Sep 19, 2007·The Journal of Membrane Biology·Loretta FerreraOscar Moran
Jun 28, 2000·Journal of the Autonomic Nervous System·J W Daly
Nov 30, 2002·Advanced Drug Delivery Reviews·Kristina Powell, Pamela L Zeitlin
Oct 19, 2001·British Journal of Pharmacology·M DuszykA W Cuthbert
Mar 18, 2000·Kidney International·P L Zeitlin
Mar 1, 1997·Archives of Disease in Childhood·K W Southern
Oct 14, 2003·American Journal of Respiratory and Critical Care Medicine·Ronald L GibsonBonnie W Ramsey
Dec 5, 2002·The Journal of Clinical Investigation·Marina S Gelman, Ron R Kopito
Feb 18, 1999·The Journal of Clinical Investigation·P L Zeitlin
Jun 27, 2002·American Journal of Pharmacogenomics : Genomics-related Research in Drug Development and Clinical Practice·O EidelmanH B Pollard
Feb 11, 1998·Lancet·B J Rosenstein, P L Zeitlin
May 12, 2004·Proceedings of the National Academy of Sciences of the United States of America·Meera SrivastavaHarvey B Pollard
Dec 16, 2000·Expert Opinion on Investigational Drugs·G M Roomans
Dec 16, 2000·Expert Opinion on Investigational Drugs·D J Wallace
Mar 17, 2010·Pulmonary Pharmacology & Therapeutics·S M RoweJ P Clancy
Sep 1, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Isabel Virella-LowellTerence R Flotte
Jan 29, 1999·Physiological Reviews·B D SchultzR J Bridges
Nov 18, 2000·American Journal of Physiology. Cell Physiology·L BulteauF Becq
Mar 26, 2003·American Journal of Physiology. Lung Cellular and Molecular Physiology·Emanuela CaciLuis J V Galietta
Jan 15, 2004·American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions·Godfried M Roomans
Dec 14, 2001·American Journal of Physiology. Lung Cellular and Molecular Physiology·B R CobbJ P Clancy
Sep 11, 2002·Biochemistry·Ofer EidelmanHarvey B Pollard

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.